Getinge AB (publ) (GETI-B.ST) stock analysis

In our weekly check, Getinge AB (publ) is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 20 pass, warnings: 3, red flags: 2.

About Getinge AB (publ)

Getinge AB (publ) is a Healthcare company (Medical - Devices) based in Sweden, listed on STO as GETI-B.ST.

What our checks show for GETI-B.ST

Red flags

• The net margin fell by 2.8 points over 5 years, to 8.2%: the company keeps less of each sale as profit.
• The stock has fallen as much as 69% from a peak. Would you have held through that?

Warning signs

• The gross margin fell by 2.8 points, to 47.4%: costs are rising faster than prices.
• The net margin is only 8.2%: little room if costs rise.
• Recovering from its deepest fall took about 2.3 years.

Strengths

• Net debt is only 1.2x a year of EBITDA: the balance sheet has room.
• Operating profit covers interest 8.5 times over.
• Operating cash flow is 1.95x net profit: the profit arrives as real cash.
• Analysts expect earnings per share to grow about 22.4% a year over the next years.
• Analysts expect the net margin to improve by 3 points from today's 8.2%.
• Free cash flow is 12.5% of revenue: cash for dividends, buybacks or growth.

Next earnings report: 2027-01-26

Similar companies

DEMANT.CO · SECT-B.ST · BSX · EW · SYK · SHL.DE

Questions

What grade does Getinge AB (publ) (GETI-B.ST) have?

In our weekly check, Getinge AB (publ) is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 20 pass, warnings: 3, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of GETI-B.ST stock?

This week's biggest flags for Getinge AB (publ): Margins falling, Deep past fall, Gross margin falling. In total 5 of 25 checks show a warning or a red flag.

What does Getinge AB (publ) do?

Getinge AB (publ) is a Healthcare company (Medical - Devices) based in Sweden, listed on STO as GETI-B.ST.

When does Getinge AB (publ) report earnings next?

The next earnings report is expected on 2027-01-26. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-31

Open the full analysis